The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10316 malaria professionals are enjoying the free benefits of MalariaWorld today


Communication: Design, Synthesis, and Study of a Mycobactin−Artemisinin Conjugate That Has Selective and Potent Activity against Tuberculosis and Malaria

January 31, 2011 - 10:24 -- Patrick Sampao
Marvin J. Miller., Andrew J. Walz., Helena I. Boshoff., et al.
Journal of the American Chemical Society

The result is that one appropriate conjugate has potent and selective activity against two of the most deadly diseases in the world.

Medical Condition: 
Medical Treatment: 
Subscribe to RSS - mycobactin